JAC Advance Access published online on March 13, 2008
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkn096
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review |
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community
1 Infection Unit, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK 2 Royal Devon & Exeter NHS Foundation Trust, Exeter EX2 5DW, UK 3 Lothian University Hospitals NHS Trust, Edinburgh EH3 9YW, UK 4 Royal Hampshire County Hospital, Winchester SO22 5DG, UK 5 Laboratory of Healthcare-Associated Infection, HPA Centre for Infections, London 9W9 5HT, UK 6 St Thomas' Hospital, Kings' College, London SE1 7EH, UK 7 HPA Southwest, Stonehouse, Gloucester GL10 3RF, UK
* Corresponding author. Tel: +44-1382-660111; Fax: +44-1382-816178; E-mail: dilip.nathwani{at}nhs.net
These guidelines have been developed by a Working Party convened on behalf of the British Society for Antimicrobial Chemotherapy. Their aim is to provide general practitioners and other community- and hospital-based healthcare professionals with pragmatic advice about when to suspect MRSA infection in the community, when and what cultures should be performed and what should be the management options, including the need for hospitalization.
Key Words: community onset , case scenarios , MRSA infection , diagnosis , management